Connor, Clark & Lunn Investment Management (CC&L)’s Astria Therapeutics ATXS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22,160
| Closed | -$198K | – | 1398 |
|
|
2024
Q4 | $198K | Buy |
+22,160
| New | +$198K | ﹤0.01% | 1327 |
|
|
2024
Q1 | – | Sell |
-13,484
| Closed | -$104K | – | 1520 |
|
|
2023
Q4 | $104K | Sell |
13,484
-28,586
| -68% | -$220K | ﹤0.01% | 1321 |
|
|
2023
Q3 | $314K | Sell |
42,070
-10,593
| -20% | -$79K | ﹤0.01% | 1126 |
|
|
2023
Q2 | $439K | Buy |
52,663
+15,144
| +40% | +$126K | ﹤0.01% | 1021 |
|
|
2023
Q1 | $499K | Buy |
37,519
+19,875
| +113% | +$264K | ﹤0.01% | 881 |
|
|
2022
Q4 | $263K | Buy |
+17,644
| New | +$263K | ﹤0.01% | 1003 |
|
|
2021
Q2 | – | Sell |
-3,042
| Closed | -$53K | – | 971 |
|
|
2021
Q1 | $53K | Buy |
+3,042
| New | +$53K | ﹤0.01% | 961 |
|